Quick Summary — BMNR scores higher on quality with 6.4/10 vs ARBK's 2.2/10. ARBK trades at $3.50 while BMNR trades at $17.97. Both analyzed daily using SEC EDGAR data across 13 institutional models.
BMNR scores higher with a 6.4/10 quality rating vs ARBK's 2.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
At $3.50, ARBK trades +80.5% above its Bayesian DCF fair value of $0.68, while BMNR at $17.97 trades +73.5% above its estimate of $4.76. ARBK shows a wider gap between price and intrinsic value.
ARBK earns a Quality of Company score of 2.2/10 compared to BMNR's 6.4/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.
ARBK carries a SAFE value trap risk (6/100) while BMNR shows SAFE risk (18/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.
Both ARBK and BMNR operate in Capital Markets, which has 86 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).
11 hidden models compare ARBK vs BMNR differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.
Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day
See All 13 Models — $0.90/dayWe don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.